# NorPACT-1 (NCT02919787)

> Nordic Pancreatic Cancer Trial (NorPACT) - 1

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT02919787
- Phase: PHASE2, PHASE3
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Oslo University Hospital
- Conditions: Pancreatic Cancer
- Interventions: 5-FU; Oxaliplatine; Irinotecan; Pancreatic surgery; 5-FU; Oxaliplatine; Irinotecan
- Enrollment: 140
- Primary outcome: Overall survival 18 month after randomization

## Indexed commentary on NorPACT-1 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 165
- Podcasts: 10
- YouTube: 9
- Bluesky threads: 3

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=norpact-1-nct02919787

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT02919787", "email": "<work email>"}; the inbox owner confirms by the emailed link.